Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial von Heier, Jeffrey S, MD, Kherani, Saleema, MD, Desai, Shilpa, MD, Dugel, Pravin, MD, Kaushal, Shalesh, MD, Cheng, Seng H, PhD, Delacono, Cheryl, OD, Purvis, Annie, MSPH, Richards, Susan, PhD, Le-Halpere, Annaig, PharmD, Connelly, John, MBA, Wadsworth, Samuel C, PhD, Varona, Rafael, MD, Buggage, Ronald, MD, Scaria, Abraham, PhD, Campochiaro, Peter A, Prof

Volltext

Mixed safety signals as a result of use of the INN “imiglucerase” for three different products that are not biosimilars: Analysis of adverse events in the Sanofi Genzyme Global Saf... von Tsang, So-Fai, Barakov, Kristina, Delacono, Cheryl, Keutzer, Joan, Lewis, Grace, Ross, Leorah

Volltext

249. Preliminary Results of a Phase 1, Open-Label, Safety and Tolerability Study of a Single Intravitreal Injection of AAV2-sFLT01 in Patients with Neovascular Age-Related Macular... von Scaria, Abraham, LeHalpere, Annaig, Purvis, Annie, Delacono, Cheryl, Cheng, Seng, Wadsworth, Samuel, Campochiaro, Peter, Heier, Jeff, Buggage, Ronald

Volltext